Find a Doctor or Practice Location

You can also search for providers and practices at Penn Medicine Lancaster General Health or Princeton Health.

within
I am searching for a
Reset Form
Anastassia Amaro, MD

Anastassia Amaro, MD Physician

Medical Director, Penn Metabolic Medicine Associate Professor of Clinical Medicine

Dr. Amaro is employed by Penn Medicine.

About Dr. Anastassia Amaro

Recognized in Philadelphia magazine's May 2019 Top Docs issue

Patient Satisfaction Ratings

Patient Rating Breakdown

The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

Comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Penn Medicine.

Overall Ratings

Clinical Specialties

Specialty:

  • Diabetes
  • Endocrinology

Programs & Centers:

Board Certification:

  • Endocrinology, Diabetes, & Metabolism, 2008
  • Obesity Medicine, 2018

Clinical Expertise:

  • Diabetes
  • Diabetes Education
  • Endocrine Disorders
  • Hypothyroidism (Underactive Thyroid)
  • Metabolic Diseases
  • Obesity
  • Polycystic Ovary Syndrome (PCOS)
  • Thyroid Disorders
  • Type 1 Diabetes
  • Type 2 Diabetes

Practice Locations and Appointments

Insurance Accepted

  • Aetna US Healthcare
  • Amerihealth Caritas
  • Amerihealth Caritas Medicare
  • Cigna
  • Cigna HealthSpring
  • Clover Health Plan
  • CVS Health
  • Devon Health Services (Americare)
  • eLAP Services
  • Gateway Health Plan
  • Geisinger Health Plan
  • HealthAmerica / HealthAssurance, a Coventry Plan
  • HealthPartners
  • HealthPartners Medicare
  • HealthSmart
  • Highmark Blue Shield
  • Homestead Smart Health Plans
  • Horizon Blue Cross Blue Shield of New Jersey
  • Humana / Choicecare
  • Independence Blue Cross (Keystone East)
  • Intergroup
  • Keystone First
  • Keystone First Medicare
  • Multiplan
  • NJ Medicaid
  • NJ Qualcare
  • Oxford Health Plan
  • PA Health and Wellness (Centene) Medicare
  • PA Medicaid
  • PA Medicare
  • Preferred Health Care/LGH
  • Provider Partners Health Plan
  • Rail Road Medicare / Palmetto GBA
  • Remedy Partners at Penn Medicine
  • Tricare
  • United Healthcare
  • UnitedHealthcare Community Plan
  • US Family Health Plan
  • Veterans Choice Program

Education and Training

Medical School: Sechenov I Moscow Medical Institute
Residency: Sechenov I Moscow Medical Institute
Residency: Advocate Lutheran General Hospital
Fellowship: Barnes-Jewish Hospital - Washington University, St. Louis

Memberships

American Association of Clinical Endocrinologists, National American Diabetes Association, National The Endocrine Society, National The Obesity Society, National

Hospital Affiliation

Dr. Amaro is employed by Penn Medicine.

Hospital Privileges:

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.

Research

Description of Research Expertise:

Diabetes and obesity clinical trials.

Selected Publications:

Amaryah Yaeger, Nancy Cash, Tara Parham, David Frankel, Rajat Deo, Robert Schaller, Pasquale Santangeli, Saman Nazarian, Gregory Supple, Jeffrey Arkles, Michael Riley, Fermin Garcia, David Lin, Andrew Epstein, David Callans, Francis Marchlinski, Daniel Kolansky, Jorge Mora, Anastassia Amaro, Richard Schwab, Allan Pack, and Sanjay Dixit.: A Nurse-Led Limited Risk Factor Modification Program to Address Obesity and Obstructive Sleep Apnea in Atrial Fibrillation Patients Journal of the American Heart Association. 2018;7:e010414 : 2018.

Amaryah Yaeger, Nancy R Cash, Tara Parham, Anastassia Amaro, Rajat Deo, David S Frankel, Andrew E Epstein, Pasquale Santangeli, Michael Riley, Saman Nazarian, David Lin, Fermin C Garcia, Robert Schaller, Jeffrey Arkles, Gregory Supple, Ramanan Kumareswaran, David J Callans, Francis E Marchlinski, and Sanjay Dixit: Efficacy of a Nurse-Led Risk Factor Modification Program in Achieving Weight Loss in Obese Atrial Fibrillation Patients Circulation: Cardiovascular Quality and Outcomes. 2018;11:A146 : 2018.

Crawford AR, Alamuddin N, Amaro A.: Cardiometabolic Effects of Anti-Obesity Pharmacotherapy Curr Atheroscler Rep. 2018:18. doi: 10.1007/s11883-018-0719-9. Review. : 2018.

Amy von Sydow Green, Ashley Bush, Anastassia Amaro and Megin Adams Myers: Group weight management classes can produce effective weight loss in a medical weight loss center Poster Presentation at the Obesity Week, Nashville, November 2018. : 2018.

ANDREW CRAWFORD, LAURA G. COONEY, NICOLE JOCHYM, ANUJA DOKRAS and ANASTASSIA AMARO: Insulin Resistance and Weight Loss in Obese Women with Polycystic Ovary Syndrome Treated with Liraglutide—Single Institution Experience Diabetes 2018 Jul; 67(Supplement 1): -. : 2018.

Thompson C., Abu Dayyeh B., Kushner R., Sullivan S., Schorr A, Amaro A, Apovian C, Fullum T, Zarrinpar A, Jensen M, Stein A, Edmundowicz S, Kahaleh M, Ryou M, Bohning J.M., Ginsberg G., Huang C, Tran D., Martin J., Jaffe D., Farraye F., Ho S., Kumar N., Harakal D., Young M., Thomas C., Shukla A., Ryan M., Haas M., Goldsmith H., McCrea J., Aronne L.: Percutaneous Gastrostomy Device for the Treatment of Class II and Class III Obesity: Results of a Randomized Controlled Trial American Journal of Gastroenterology 112 (3): 447-457,2017.

Chantal Lewis MB,BS; Julia Kharlip MD; Anastassia Amaro MD : Use of Liraglutide in Childhood Onset Non-Craniopharyngioma Related Hypothalamic Obesity. Poster presentation at the Obesity Society annual meeting, Los Angeles, CA in November 2015. : 2015.

Vetter ML, Amaro A, Volger S.: Nutritional management of type 2 diabetes mellitus and obesity and pharmacologic therapies to facilitate weight loss. Postgrad Med. 2014 Jan;126(1):139-52. : 2014.

Amaro A., Fabbrini E., Kars M., Yue P, Schonfeld G., Klein S.: Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia Gastroenterology 139 (1): 149-153,2010.

Amaro A., Kars M., Fabbrini E., Mohammed B., Yue P, Schonfeld G., Klein S.: Increased intrahepatic triglyceride content does not cause insulin resistance in subjects with familial hypobetalipoproteinemia The Obesity Society Annual Scientific Meeting, Washington, DC : 2009.

Academic Contact Info

Penn Rodebaugh Diabetes Center
Perelman Center for Advanced Medicine
Suite 4-900W
3400 Civic Center Blvd

Philadelphia, PA 19104
Phone: (215) 662-2468
Patient appointments: 800-789-7366 (PENN)